Abrdn Life Sciences Investors (NYSE:HQL – Get Free Report) declared a quarterly dividend on Monday, August 12th, Wall Street Journal reports. Investors of record on Friday, August 23rd will be paid a dividend of 0.49 per share on Monday, September 30th. This represents a $1.96 dividend on an annualized basis and a yield of 12.92%. The ex-dividend date is Friday, August 23rd. This is a positive change from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.48.
Abrdn Life Sciences Investors Trading Down 0.3 %
Abrdn Life Sciences Investors stock traded down $0.05 during midday trading on Monday, reaching $15.17. The stock had a trading volume of 46,146 shares, compared to its average volume of 102,868. The firm’s fifty day simple moving average is $14.52 and its two-hundred day simple moving average is $13.92. Abrdn Life Sciences Investors has a twelve month low of $11.34 and a twelve month high of $15.63.
Insider Transactions at Abrdn Life Sciences Investors
In related news, major shareholder Saba Capital Management, L.P. bought 8,714 shares of the firm’s stock in a transaction on Tuesday, May 28th. The stock was bought at an average price of $13.38 per share, with a total value of $116,593.32. Following the purchase, the insider now directly owns 3,260,597 shares of the company’s stock, valued at approximately $43,626,787.86. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Insiders purchased 115,412 shares of company stock valued at $1,596,623 over the last three months. 10.06% of the stock is owned by corporate insiders.
About Abrdn Life Sciences Investors
Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.
Further Reading
- Five stocks we like better than Abrdn Life Sciences Investors
- Dividend Capture Strategy: What You Need to Know
- How to Invest in Silver: A Beginner’s Guide
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Monday.com’s Stock Results Will Brighten Any Investor’s Week
- 3 Home Improvement Stocks that Can Upgrade Your Portfolio
- 3 Must-Watch Stocks After a Bullish Goldman Sachs Recommendation
Receive News & Ratings for Abrdn Life Sciences Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abrdn Life Sciences Investors and related companies with MarketBeat.com's FREE daily email newsletter.